Evidence map›Paper›PMID 34966411›Full record

ArticleFrontiers in genetics2021

Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration.

Chun Zhang, Lisha Chang, Yizhen Yao, Ce Chao, Zhongchun Ge, Chengfeng Fan, Hualin Yu, Bin Wang, Jingsong Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Chun ZhangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Lisha ChangDepartment of Oncology, Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Yizhen YaoDepartment of Respiratory Medicine, Nanjing Yuhua Hospital, Yuhua Branch of Nanjing First Hospital, Nanjing, China.
Ce ChaoDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Zhongchun GeDepartment of Cardiology, People's Hospital of Xuyi, Xuyi, China.
Chengfeng FanDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Hualin YuDepartment of Radiotherapy, Nantong Third People's Hospital, Nantong University, Nantong, China.
Bin WangDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Jingsong YangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNSoochow University · CNNantong University · CNSecond Affiliated Hospital of Nanjing Medical University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CBX molecular familyimmune infiltrationlung adenocarcinomaprognosistumorigenesis

Identifiers

PMID34966411
PMCPMC8710700
OpenAlexW4200287768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.